For example:
The U.S. Food and Drug Administration classifies clinical trials according to a sequence of research phases.
Although clinical trials are intended to validate the safety and efficacy of developmental drugs for population groups at large, they often constitute the best — or perhaps only — life-extending or lifesaving therapy option for many clinical trial participants.
In a cancer clinical trial, no patient goes without treatment if there is any known treatment that could benefit that patient. If it becomes clear during a clinical trial that one treatment is better than another, the trial is stopped and all patients in the trial are offered the more effective treatment. A trial will also be stopped early if an experimental treatment is found to be ineffective or harmful.
The doctors and nurses managing a clinical trial follow a carefully designed treatment plan known as a protocol. The protocol spells out exactly what and why certain procedures will be done, at what intervals, and how patients will be protected by close monitoring.
The National Cancer Institute and National Institutes of Health offer information about cancer clinical trials at the following Web sites:
You can also get information about clinical trials by calling the National Cancer Institute's Cancer Information Service at 1-800-4-CANCER.
Adult cancer clinical trials: 916-734-0565
Pediatric cancer clinical trials: 916-734-2780
Phase 1 clinical trials: 916-703-5558